Linda R Greene Rochester General Hospital Rochester, NY

Slides:



Advertisements
Similar presentations
Surgical Site Infections (SSIs): What the Direct Caregiver Should Know
Advertisements

Prevention of Ventilator Associated Pneumonia
PREVENTION OF CATHETER ASSOCIATED URINARY TRACT INFECTIONS (CAUTIs)
Eliminate Ventilator-Associated Pneumonia. What Is a Ventilator? A machine that supports breathing for those that have lost the ability to breathe Short.
Reducing Ventilator Associated Pneumonia in Adults Intensive Care Units Confidential: Quality Improvement Material.
Implementing a Ventilator-Associated Pneumonia Bundle in an Academic Emergency Department L.A. DeLuca, L.R. Stoneking, K. Grall, A. Tran, J. Rosell, A.
Ventilator Care Bundle
How We Zapped VAP During the past six years, our Multidisciplinary Pneumonia Team has worked to reduce Ventilator Associated Pneumonia (VAP). Through these.
OUR LADY OF LOURDES MEMORIAL HOSPITAL Binghamton, New York Reducing Complications From Ventilators in ICU: Ventilator Associated Pneumonia (VAP)
Ventilator Associated Pneumonia (VAP)
University of DundeeSchool of Medicine Best practice in managing pneumonia: Scottish National Audit Project – Community Acquired Pneumonia (SNAP-CAP) Peter.
Ventilator Associated Pneumonia Best Practice Amy Shay, MS, CCRN, CNS Amy Shay, MS, CCRN, CNS.
Sean Berenholtz, MD MHS FCCM September 20, 2011 at 2ET/1 CT/12 MT/11 PT Ventilator Associated Pneumonia Prevention CLABSI Supplemental Call Series.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
The Importance of Clinical Oral Care
Journal Club. Background to the paper Pneumonia is THE MOST COMMON nosocomial infection in ICU patients 12 to 18 cases per 1000 ventilator days Oropharyngeal.
Current Challenges in the ICU Prof Craig Williams Institute of Healthcare Associated Infection UWS.
Ventilator Associated Pneumonia Overview
Safer Healthcare Now! Ventilator Acquired Pneumonia Presented by Amanda Thompson, Safer Healthcare Now Facilitator April 12, 2007.
Preventing VAP - evidence for a care bundle. VAP Incidence ~ % ventilated patients 7-15 / 1000 ventilator days Atributable mortality of 0-50% Atributable.
What are they & why use them?
Biofilms on Medical Devices
Reports: Daily Process, VAE, NHSN
Prevention of Nosocomial Infections
CLABSI: Working Toward Zero Trinity Regional Health System Infection Prevention and Control Presented by: Patricia Herath, BSN, RNC Infection Preventionist.
University of Rochester Strong Health
Oral Care for Patients at Risk for Ventilator-Associated Pneumonia Issued April 2010.
GENERAL TEMPLATE FOR A 48”X36” POSTER Name(s) of Author(s) 1 ; Name(s) of Author(s) 2 ; Name(s) of Author(s) 3 1. Name of Institution; 2. Name on Institution;
VAP Intervention Information
Infections in the intensive care unit Wanida Paoin Thammasat University.
Hospital Acquired Infections Ernest Oppong & Leyla Chiepodeu University of Virginia’s College at Wise Nursing BACKGROUNDPURPOSE Hospital associated infections.
Nosocomial Pneumonia Hospital Acquired, Ventilator Associated, Healthcare Associated Pneumonia.
Clinical Uses and Ramifications of VAE Data
The Cardiac Surgery Translational Study (“CSTS”) The Quality And Safety Research Group Ventilator Associated Pneumonia Prevention Sean Berenholtz, MD MHS.
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
Pneumonia Dr. Abdul-Monim Batiha Assistant Professor Critical Care Nursing Philadelphia university.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 VAP Prevention Bundle: Evidence Review for Oral Care and Subglottic.
ความหมาย As Pneumonia in patient who have been on mechanical ventilation for greater than 48 hrs.
Lou Ann Bruno, MD Chief of Infectious Diseases and Medical Director Of Infection Prevention NHSN Benchmark Med-Surg ICU:
Catholic Medical Center Rapid Response Teams
TEMPLATE DESIGN © Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to COPD.
***Please note some slides have been removed since the webinar at the presenter’s request. CUSP for VAP Revisiting Your Action Plan: Using Reports to.
Results: The Staff Safety Assessment Survey Lisa Lubomski, PhD April 11, 2013.
Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.
CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Data Feedback: SubG ETT, Head of Bed Elevation and Delirium Assessment Utilization.
Outlines At the completion of this lecture the student will be able to identify the concept and related terms of: Infection- Infection control-
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals 2014 Update Dr Neda Alijani.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 Providing Feedback: Structural Assessment 2 Results & Exposure Receipt.
Process and Outcome Measures Ventilator Management Redesign Effort.
PREVENTION Kaplan University Capstone NU499 VENTILATOR – ASSOCIATED PNEUMONIA VAP PREVENTION at Sparks Regional Medical Center.
E A B C D Reducing Delirium in the ICU Patient: The ABCDE Bundle
VAP Rates – Critical Care January 1, 2010 – December 31, 2010.
Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.
Using Subglottic Endotracheal Tubes in Preventing Ventilator Assisted Pneumonia By: Nicole Durrance, Adriana Gomez, Esther Gonzalez, Marzette Solis BACKGROUND.
LSU Journal Club Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia A Systematic Review and Meta-analysis Scott Hebert,
VAE/VAP: Definitions, Algorithms and Best Practices
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Yousef I. Aljeesh, PhD, RN Said Abusalem, PhD, RN Naeem Alkariri, MSN, RN John A. Myers, PhD, MSPH Fawwaz Alaloul, PhD, RN Staff Developed IP Program Increases.
Ventilator-Associated Pneumonia
Purpose To decrease the number of Ventilator-Associated Pneumonias (VAP) at the SMBD-JGH.
Update in Critical Care Medicine Ann Intern Med 2007;147:
Enhanced Recovery After Surgery Alan Willson 17 November 2010
Linda L. Horton, RN, MSN, CPHQ Mercy Hospital Buffalo January 18, 2012
Ventilator-associated pneumonia (VAP) prevention in Wales:
Advanced Ventilation Research
Subglottic Suctioning
A Quick Review: Preventing Ventilator-Associated Pneumonia (VAP)
Surveillance of Post-operative pneumonia
Presentation transcript:

Linda R Greene Rochester General Hospital Rochester, NY

Nothing to Declare

 Describe the epidemiology and pathogenesis of ventilator associated pneumonia  Compare and contrast the current definition of ventilator associated pneumonia with the proposed revised definition  List at least 3 evidence based practices to prevent ventilator associated pneumonia.  Discuss future trends and strategies in prevention  ventilator associated pneumonia

Early Work On VAP Prevention

GAO Report on HAIs in hospitals April 2008

 Leadership needed from HHS to prioritize preventive practices  Improve central coordination  Identify priorities  Increase reliable estimates of HAIs

The literature supporting high-profile measures to reduce ventilator-associated pneumonia (VAP): Many studies show significant reductions in VAP rates but almost none show any impact on patients' duration of mechanical ventilation, length of stay in the intensive care unit and hospital, or mortalitY Klompas M, Platt R. Ventilator-associated pneumonia – the wrong quality measure for benchmarking. Ann Intern Med. 2007;147:

 Lack of specificity in the VAP definition  Array of events from critical to benign  Benign events may actually capture colonization

Pleural effusion or atelectasis however, pneumonia cannot be rule out Opacities in lower lobe may be atalectasis, pneumonia or emphysematous changes Bibasilar changes which may represent atelectasis, pneumonia or edema

Must be vetted with Physicians Start with sputum specimen Daily rounding Daily review of CXR Determination by ICU Staff Differences in NYS among IPs collecting data

Prevention Strategies Bundles Burden on IP – less time for surveillance

 Pressure to have a VAP outcome measure for public reporting

 Stakeholder meetings  VAP working group  Objective Definition  Clinically relevant

 Representation from all major stakeholder groups: CDC IDSA CSTE APIC SHEA ATS Critical Care Society

VAP sVAP VAC Valor i

Mechanical ventilation is primary risk factor: The endotrachel tube acts as a conduit from the upper respiratory tract to the lower respiratory tract Secretions collect on and around the cuff causing leakage of fluids into the lower respiratory tract Sedation inhibits the natural ability to clear secretions Patients undergoing mechanical ventilation are frequently fed via nasogastric tubes contributing to aspiration Critically ill patients are often maintained in a supine position Activity is limited

Cuffs: current recommendation is that cuff pressure should be maintained at no less than 20 cm H2O Some controversy that cuff design may be more important Than cuff pressure Tube related issues primarily include aspiration of contaminated secretions from above the cuff

LocationDefense Mechanism Upper Airway NasopharynxNasal Hairs Turbinates Upper airway anatomy Mucociliary apparatus IgA secretions OropharynxSaliva Sloughing of epithelial cells Bacterial Interference Complement Production

LocationDefense Mechanism Conducting Airways Trachea, BrochiiCoughing, epiglottic reflexes Airway branching Mucocillary apparatus Immunoglobulin production Airway Surface Liquid Lower Airways Terminal airways Alveoli Alveolar lining fluid Cytokines Alveolar Macrophages Polymorohonuclear Leukocytes Cell- mediated Immunity

What about Prevention Efforts?

If unable to bend at the hip - use Reverse Trendelenberg

 Head of bed elevation: controversial, hard to maintain, but still recommended by most authors.  Must be at least 30 degrees, and must measure, not estimate

Reduced VAP incidence in some studies but not others, does not hold up in metanalysis Probably good for reducing length of ventilation and ICU stay though

 Not part of original bundle  Chlorohexidine recommended in increasing number of studies: Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia Koehman et alAmerican Journal of Respiratory and Critical Care Medicine Vol 173. pp , (2006) © 2006 American Thoracic SocietyAmerican Thoracic Society

Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. Chan et. Al BMJ 2007, 334:889. Randomized Controlled Trial and Meta-analysis of Oral Decontamination with 2% Chlorhexidine Solution for the Prevention of Ventilator-Associated Pneumonia Tantipong et L infection control and hospital epidemiology february 2008, vol. 29, no. 2

 Effect of oral hygiene with o.12% chlorohexidine gluconate on the Incidence of Nosocomial Pneumonia in children undergoing cardiac surgery Jacomo et al. ICHE et al. June 2011 vol 3 no 6

The Basic Bundle HOB Monitoring Sedation Vacation PUD Prophylaxis DVT prophylaxis Enhanced Bundle Mouth Care- consider chlorohexidine Education and Training Program New Generation ET tubes Oral gastric tubes Ambulation

Antimicrobial coating of ET tubes e.g., silver coating, silver-sulfadiazene, chlorhexidine- recommended by some BIOFILM - Once microorganisms have made contact and formed an attachment with a living host or non-living surface or object, development of a biofilm can take place. Bacteria living in a biofilm can have significantly different properties from free-floating bacteria, as the dense extracellular matrix of biofilm and the outer layer of cells may protect the bacteria from antibiotics and normal host defense mechanisms of the white blood cells, such as phagocytosis Rationale

 Avoid Intubation if possible -Non-invasive ventilation: avoiding intubation will avoid VAP, so use NIV whenever possible  Weaning: the longer you are on the ventilator, the more likely you are to get VAP. Weaning protocols have been conclusively shown to improve the rate of weaning from the ventilator

Implementation Science – How do we get evidence to the bedside ? We have to take a closer look at processes

EngageEducateExecuteEvaluate

Staff Education & Training!

staff feedback!

Months without a VAP 10 mo 1 mo

 Look at other outcomes  Mortality, readmission rates, length of stay  Use data to continually evaluate effectiveness of interventions

 Communicate consistently: disseminate results of process and outcome measures.  Connect to purpose: help staff understand how simple actions connect to outcomes.  Review Deviations: review all cases to identify opportunities and system issues.